antibiotics

First Opinion By David Hyun and Rachel Zetts

Many hospitalized Covid-19 patients are given antibiotics. That’s a problem

Pharmalot By Ed Silverman

EPA rule that could help citrus growers is challenged over concerns about antibiotic resistance

Pharmalot By Ed Silverman

Antibiotic stewardship may be improving at U.S. hospitals, but new targets are still needed

Pharmalot By Ed Silverman

Antibiotic prescribing during the pandemic raises concern about drug resistance

Health By Matthew Herper and Ed Silverman

Virtual Event: Facing the crisis of drug-resistant germs

Pharmalot By Ed Silverman

Pharma’s ambitious new antibiotic venture hires a CEO to fix a ‘broken’ pipeline

Pharma By Ed Silverman

New bill would create a subscription payment model to jumpstart antibiotic development

Pharmalot By Ed Silverman

Doctors say antibiotic resistance is an issue — but most say they’re not part of the problem

First Opinion By Kevin Outterson and John Rex

We need new antimicrobials to prevent the next infectious disease crisis

Special Report By Gardiner Harris and Alex W. Palmer — The Wire

China has near-total control of the world’s antibiotic supply. Is America at risk as a result?

First Opinion By Isaac Stoner

Saving lives should be good business. Why doesn’t that apply to finding new antibiotics?

Pharmalot By Ed Silverman

WHO adviser says an antimicrobial fund can help a market that ‘needs to be fixed’

Pharmalot By Ed Silverman

Pharmalittle: France indicts Sanofi over epilepsy drug risks; Trump talk of drug pricing in SOTU speech may backfire

First Opinion By Alba Tiley and Steve Brooks

Companies must responsibly manufacture the antimicrobials society needs

First Opinion By Allan Coukell

Antibiotics need a special place in the drug pricing debate

Pharmalot By Ed Silverman

Amid fears of superbugs, sales of antibiotics used in food-producing livestock rose last year

First Opinion By Alex M. Azar II and Robert R. Redfield

U.S. continues to lead the fight against antibiotic resistance

Health By Helen Branswell

CDC report: 35,000 Americans die of antibiotic-resistant infections each year

First Opinion By Seema Verma

Seema Verma: CMS’s ‘expanded pathway’ for new antibiotics can help fight antimicrobial resistance

Pharmalot By Ed Silverman

Pharmalittle: Biogen resurrects an Alzheimer’s drug; last-minute settlement in a big opioid trial

Pharmalot By Ed Silverman

The use of antibiotics in food-producing livestock continues to drop in most of Europe

First Opinion By Manos Perros

Wanted: better policies and incentives to revitalize R&D for new antimicrobial drugs

Pharmalot By Ed Silverman

Pharmalittle: Opioid judge refuses to disqualify himself; Biocon to lower insulin price in some countries

Pharmalot By Ed Silverman

Pharmalittle: Pelosi plan rests with Dems who get big pharma bucks; Novartis recalls heartburn meds from U.S.

Pharmalot By Ed Silverman

Antibiotic resistance in food-producing animals surges in low- and middle-income countries